NCT06241352View on ClinicalTrials.gov

Statin Addition to Chemotherapy for Advanced Pancreatic Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

March 20, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
Advanced Pancreatic Cancer
Interventions
DRUG

statin addition to chemotherapy

Chemotherapy was administered along with 80mg of atorvastatin per day. Atorvastatin was discontinued when CA19-9 levels (with CA19-9 negative patients referenced against CEA or CA-125) rose more than 20% above baseline.

Trial Locations (1)

200433

Changhai Hospital, Shanghai

All Listed Sponsors
lead

Changhai Hospital

OTHER

NCT06241352 - Statin Addition to Chemotherapy for Advanced Pancreatic Cancer | Biotech Hunter | Biotech Hunter